Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other Non-Current Assets (2022 - 2024)

Praxis Precision Medicines has reported Other Non-Current Assets over the past 3 years, most recently at $416000.0 for Q4 2024.

  • Quarterly results put Other Non-Current Assets at $416000.0 for Q4 2024, changed 0.0% from a year ago — trailing twelve months through Dec 2024 was $416000.0 (changed 0.0% YoY), and the annual figure for FY2024 was $416000.0, changed 0.0%.
  • Other Non-Current Assets for Q4 2024 was $416000.0 at Praxis Precision Medicines, roughly flat from $416000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PRAX hit a ceiling of $416000.0 in Q1 2022 and a floor of $416000.0 in Q1 2022.
  • Median Other Non-Current Assets over the past 3 years was $416000.0 (2022), compared with a mean of $416000.0.
  • Peak annual rise in Other Non-Current Assets hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Praxis Precision Medicines' Other Non-Current Assets stood at $416000.0 in 2022, then changed by 0.0% to $416000.0 in 2023, then changed by 0.0% to $416000.0 in 2024.
  • The last three reported values for Other Non-Current Assets were $416000.0 (Q4 2024), $416000.0 (Q3 2024), and $416000.0 (Q2 2024) per Business Quant data.